Kamyar Asadipooya

1.0k total citations
32 papers, 699 citations indexed

About

Kamyar Asadipooya is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Kamyar Asadipooya has authored 32 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Kamyar Asadipooya's work include Bone health and treatments (8 papers), COVID-19 Clinical Research Studies (6 papers) and Parathyroid Disorders and Treatments (6 papers). Kamyar Asadipooya is often cited by papers focused on Bone health and treatments (8 papers), COVID-19 Clinical Research Studies (6 papers) and Parathyroid Disorders and Treatments (6 papers). Kamyar Asadipooya collaborates with scholars based in United States, Iran and Egypt. Kamyar Asadipooya's co-authors include Mohammadreza Kalantarhormozi, Greene Lw, Leland Graves, Ada Weinstock, Iraj Nabipour, Amr El‐Husseini, Mostafa Abdelsalam, Rishi Raj, Kamran Bagheri Lankarani and Majid Assadi and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Medicine and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Kamyar Asadipooya

29 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamyar Asadipooya United States 13 232 170 134 122 107 32 699
Pedro Rozas-Moreno Spain 13 370 1.6× 376 2.2× 190 1.4× 203 1.7× 88 0.8× 32 879
Silvia Briganti Italy 15 80 0.3× 123 0.7× 210 1.6× 67 0.5× 174 1.6× 26 659
Peter Oelzner Germany 19 186 0.8× 259 1.5× 53 0.4× 126 1.0× 110 1.0× 92 1.1k
Danuta Fedak Poland 15 48 0.2× 140 0.8× 84 0.6× 56 0.5× 108 1.0× 43 615
Stephen Hough South Africa 17 380 1.6× 348 2.0× 153 1.1× 173 1.4× 149 1.4× 35 947
Vikram Vinod Shanbhogue Denmark 14 651 2.8× 388 2.3× 195 1.5× 298 2.4× 228 2.1× 22 1.1k
Meena Desai India 18 197 0.8× 338 2.0× 395 2.9× 122 1.0× 204 1.9× 79 1.1k
Subhashini Yaturu United States 15 176 0.8× 289 1.7× 313 2.3× 183 1.5× 171 1.6× 34 976
Rebeca Reyes‐García Spain 18 472 2.0× 475 2.8× 302 2.3× 311 2.5× 139 1.3× 84 1.3k
Yandong Liu China 21 154 0.7× 327 1.9× 54 0.4× 88 0.7× 239 2.2× 74 1.1k

Countries citing papers authored by Kamyar Asadipooya

Since Specialization
Citations

This map shows the geographic impact of Kamyar Asadipooya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamyar Asadipooya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamyar Asadipooya more than expected).

Fields of papers citing papers by Kamyar Asadipooya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamyar Asadipooya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamyar Asadipooya. The network helps show where Kamyar Asadipooya may publish in the future.

Co-authorship network of co-authors of Kamyar Asadipooya

This figure shows the co-authorship network connecting the top 25 collaborators of Kamyar Asadipooya. A scholar is included among the top collaborators of Kamyar Asadipooya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamyar Asadipooya. Kamyar Asadipooya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dixon, Sewell H., et al.. (2025). Thyroid disorders and COVID-19: a comprehensive review of literature. Frontiers in Endocrinology. 16. 1535169–1535169.
2.
Lw, Greene, et al.. (2025). Management of skeletal-related events and fracture prevention in systemic mastocytosis. Osteoporosis International.
3.
Asadipooya, Kamyar, et al.. (2024). Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review. Archives of Virology. 169(6). 122–122. 4 indexed citations
4.
Asadipooya, Kamyar, et al.. (2023). Type1 Diabetes and COVID-19: A Systematic Review and Possible Management. Preprints.org. 1 indexed citations
5.
Davarpanah, Mohammad Ali, et al.. (2023). Combination of spironolactone and sitagliptin improves clinical outcomes of outpatients with COVID-19: a prospective cohort study. Journal of Endocrinological Investigation. 47(1). 235–243. 3 indexed citations
6.
Asadipooya, Kamyar, et al.. (2023). Type 1 Diabetes and COVID-19: A Literature Review and Possible Management. International Journal of Endocrinology and Metabolism. 21(4). e139768–e139768. 5 indexed citations
7.
Abdelsalam, Mostafa, et al.. (2022). Management of osteoporosis in patients with chronic kidney disease. Osteoporosis International. 33(11). 2259–2274. 41 indexed citations
8.
Asadipooya, Kamyar, et al.. (2022). Metainflammation in COVID-19. Endocrine Metabolic & Immune Disorders - Drug Targets. 22(12). 1154–1166. 7 indexed citations
9.
Asadipooya, Kamyar, et al.. (2021). Bone Quality in CKD Patients: Current Concepts and Future Directions – Part I. SHILAP Revista de lepidopterología. 7(4). 268–277. 14 indexed citations
10.
Kalantarhormozi, Mohammadreza, et al.. (2020). Evaluation of adipokines, adiponectin, visfatin, and omentin, in uncomplicated type I diabetes patients before and after treatment of diabetic ketoacidosis. Journal of Endocrinological Investigation. 43(12). 1723–1727. 1 indexed citations
11.
Raj, Rishi, et al.. (2019). Delivery of Euthyroid Baby following Hyperthyroidism in Twin Gestation with Coexisting Complete Hydatidiform Mole. Case Reports in Endocrinology. 2019. 1–6. 6 indexed citations
12.
Asadipooya, Kamyar, Kamran Bagheri Lankarani, Rishi Raj, & Mohammadreza Kalantarhormozi. (2019). RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease. International Journal of Endocrinology. 2019. 1–11. 39 indexed citations
13.
Asadipooya, Kamyar, Leland Graves, & Greene Lw. (2017). Transient osteoporosis of the hip: review of the literature. Osteoporosis International. 28(6). 1805–1816. 68 indexed citations
14.
Lw, Greene, et al.. (2016). Endocrine manifestations of systemic mastocytosis in bone. Reviews in Endocrine and Metabolic Disorders. 17(3). 419–431. 27 indexed citations
15.
Kalantarhormozi, Mohammadreza, Majid Assadi, Katayoun Vahdat, et al.. (2015). Chlamydia pneumoniae and Helicobacter pylori IgG seropositivities are not predictors of osteoporosis-associated bone loss: a prospective cohort study. Journal of Bone and Mineral Metabolism. 34(4). 422–428. 15 indexed citations
16.
Asadipooya, Kamyar, et al.. (2013). Treatment of Iron-deficiency Anemia in Patients with Subclinical Hypothyroidism. The American Journal of Medicine. 126(5). 420–424. 45 indexed citations
17.
Movahed, Ali, Bagher Larijani, Iraj Nabipour, et al.. (2012). Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism. Journal of Bone and Mineral Metabolism. 30(6). 683–691. 62 indexed citations
18.
Asadipooya, Kamyar, et al.. (2011). Short-course treatment in neurobrucellosis: A study in Iran. Neurology India. 59(1). 101–101. 10 indexed citations
19.
Asadipooya, Kamyar, Mohammadreza Kalantarhormozi, & Iraj Nabipour. (2011). Pioglitazone reduces central obesity in polycystic ovary syndrome women. Gynecological Endocrinology. 28(1). 16–19. 4 indexed citations
20.
Karimi, Mehran, Ali A. Asadi‐Pooya, Bijan Khademi, Kamyar Asadipooya, & Hooman Yarmohammadi. (2002). Evaluation of the Incidence of Sensorineural Hearing Loss in Beta-Thalassemia major Patients under Regular Chelation Therapy with Desferrioxamine. Acta Haematologica. 108(2). 79–83. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pedro Rozas-Moreno Breakdown of academic impact, for papers by Silvia Briganti Breakdown of academic impact, for papers by Peter Oelzner Breakdown of academic impact, for papers by Danuta Fedak Breakdown of academic impact, for papers by Stephen Hough Breakdown of academic impact, for papers by Vikram Vinod Shanbhogue Breakdown of academic impact, for papers by Meena Desai Breakdown of academic impact, for papers by Subhashini Yaturu Breakdown of academic impact, for papers by Rebeca Reyes‐García Breakdown of academic impact, for papers by Yandong Liu
Rankless by CCL
2026